Allianz Asset Management GmbH - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$10,071,000
-22.2%
58,284
-48.3%
0.01%
-21.4%
Q4 2014$12,948,000
-78.8%
112,656
-71.6%
0.01%
-81.1%
Q3 2014$61,050,000
+50.1%
396,053
+20.1%
0.07%
+45.1%
Q2 2014$40,678,000
+52.5%
329,771
+26.9%
0.05%
+59.4%
Q1 2014$26,678,000
+94.3%
259,964
+70.3%
0.03%
+88.2%
Q4 2013$13,732,000
+97.5%
152,687
+46.9%
0.02%
+88.9%
Q3 2013$6,952,000
+12.4%
103,957
+11.2%
0.01%0.0%
Q2 2013$6,184,00093,4840.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders